BR0206367A - Uso de antigestágenos para inibir o amadurecimento endométrico acelerado durante o tratamento da infertilidade - Google Patents

Uso de antigestágenos para inibir o amadurecimento endométrico acelerado durante o tratamento da infertilidade

Info

Publication number
BR0206367A
BR0206367A BR0206367-0A BR0206367A BR0206367A BR 0206367 A BR0206367 A BR 0206367A BR 0206367 A BR0206367 A BR 0206367A BR 0206367 A BR0206367 A BR 0206367A
Authority
BR
Brazil
Prior art keywords
antigest
infertility treatment
maturation during
during infertility
endometrial maturation
Prior art date
Application number
BR0206367-0A
Other languages
English (en)
Inventor
Christa Hegele-Hartung
Holger Hess-Stumpp
Henning M Beier
Claudia Krusche
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/801,925 external-priority patent/US20020143000A1/en
Application filed by Schering Ag filed Critical Schering Ag
Publication of BR0206367A publication Critical patent/BR0206367A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

"USO DE ANTIGESTáGENOS PARA INIBIR O AMADURECIMENTO ENDOMéTRICO ACELERADO DURANTE O TRATAMENTO DA INFERTILIDADE". Um método para inibir a ocorrência de amadurecimento endométrico avançado em um mamífero do sexo feminino sofrendo tratamento de fertilidade é descrito. O método compreende a administração de pelo menos um antagonista de receptor de progesterona 17 <244>-fluoroalquilada ao mamífero do sexo feminino.
BR0206367-0A 2001-01-09 2002-01-09 Uso de antigestágenos para inibir o amadurecimento endométrico acelerado durante o tratamento da infertilidade BR0206367A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75628601A 2001-01-09 2001-01-09
US09/801,925 US20020143000A1 (en) 2001-01-09 2001-03-09 Use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment
PCT/IB2002/001764 WO2002067910A2 (en) 2001-01-09 2002-01-09 The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment

Publications (1)

Publication Number Publication Date
BR0206367A true BR0206367A (pt) 2003-12-23

Family

ID=27116200

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0206367-0A BR0206367A (pt) 2001-01-09 2002-01-09 Uso de antigestágenos para inibir o amadurecimento endométrico acelerado durante o tratamento da infertilidade

Country Status (25)

Country Link
US (1) US20040152684A1 (pt)
EP (1) EP1365765B1 (pt)
JP (1) JP2004520411A (pt)
CN (1) CN1244329C (pt)
AR (1) AR032390A1 (pt)
AT (1) ATE367817T1 (pt)
AU (1) AU2002253488B2 (pt)
BG (1) BG107977A (pt)
BR (1) BR0206367A (pt)
CA (1) CA2433776A1 (pt)
CZ (1) CZ20031864A3 (pt)
DE (1) DE60221359T2 (pt)
DK (1) DK1365765T3 (pt)
EE (1) EE200300321A (pt)
ES (1) ES2290284T3 (pt)
HK (1) HK1065953A1 (pt)
HR (1) HRP20030628A2 (pt)
HU (1) HUP0302632A2 (pt)
IL (1) IL156729A0 (pt)
MX (1) MXPA03006156A (pt)
NO (1) NO20033125L (pt)
NZ (1) NZ526908A (pt)
PL (1) PL361689A1 (pt)
SK (1) SK8612003A3 (pt)
WO (1) WO2002067910A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009034362A1 (de) * 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de) * 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) * 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
US20130029953A1 (en) * 2011-07-28 2013-01-31 Klaus Nickisch Progesterone antagonists
ES2716862T3 (es) * 2014-12-22 2019-06-17 Ferring Bv Terapia con antagonistas del receptor de oxitocina en la fase lútea para la implantación y embarazo en mujeres que se someten a tecnologías de reproducción asistida
EP3214092A1 (en) 2016-03-04 2017-09-06 Bayer Pharma Aktiengesellschaft Prodrugs of the selective progesterone receptor modulator (sprm) (11.beta.,17.beta.)-17-hydroxy-11-[4-(methylsulphonyl)phenyl]-17-(pentafluoroethyl)estra-4,9-dien-3-one

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3533175A1 (de) * 1985-09-13 1987-03-19 Schering Ag Antigestagene zur verschiebung der endometrialen reifung
DE19706061A1 (de) * 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
DE19860719A1 (de) * 1998-12-23 2000-06-29 Schering Ag Neue Testosteronderivate und ihre Verwendung zur Langzeittherapie von Androgen-abhängigen Erkrankungen

Also Published As

Publication number Publication date
HRP20030628A2 (en) 2005-06-30
JP2004520411A (ja) 2004-07-08
US20040152684A1 (en) 2004-08-05
NO20033125L (no) 2003-09-09
CN1496263A (zh) 2004-05-12
BG107977A (bg) 2004-08-31
CA2433776A1 (en) 2002-09-06
IL156729A0 (en) 2004-02-08
DE60221359D1 (de) 2007-09-06
PL361689A1 (en) 2004-10-04
NO20033125D0 (no) 2003-07-08
EE200300321A (et) 2003-10-15
HUP0302632A2 (hu) 2003-11-28
ES2290284T3 (es) 2008-02-16
HK1065953A1 (en) 2005-03-11
AR032390A1 (es) 2003-11-05
DE60221359T2 (de) 2008-04-17
CN1244329C (zh) 2006-03-08
SK8612003A3 (en) 2004-03-02
WO2002067910A2 (en) 2002-09-06
CZ20031864A3 (en) 2004-03-17
DK1365765T3 (da) 2007-10-29
MXPA03006156A (es) 2003-09-16
WO2002067910A3 (en) 2003-02-06
AU2002253488B2 (en) 2007-02-15
NZ526908A (en) 2005-07-29
EP1365765A2 (en) 2003-12-03
EP1365765B1 (en) 2007-07-25
ATE367817T1 (de) 2007-08-15

Similar Documents

Publication Publication Date Title
ES2553101T3 (es) Precursor de esteroides sexuales en combinación con un modulador selectivo del receptor de estrógenos para la prevención y tratamiento de atrofia vaginal en mujeres postmenopáusicas
DE69620241D1 (de) Gonadotropin releasing hormon- antagonisten
AU2003290383A1 (en) Use of gnrh agonists to support the luteal phase during infertility treatment
MX9804850A (es) Antagonistas de hormona liberadora de gonadotropina.
HUP0300335A2 (hu) 8béta-hidrokarbil-szubsztituált ösztratriének mint szelektív hatású ösztrogének, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
NZ325060A (en) Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone
BRPI0512993A (pt) uso de um antagonista de pr, kit farmaceuticamente últil, e, método de contracepção em uma fêmea em idade de parto
BR9908094A (pt) Preparado combinado de estrogênio e antiestrogênio
BR0114758A (pt) Inibidores do receptor ep4 para tratamento de artrite reumatóide
PT868188E (pt) Kit para a contracepcao em mamiferos femininos consistindo numa combinacao de gestagenio e estrogenio
MXPA03001859A (es) Metodo para incrementar en la mujer testosterona y concentraciones de esteroides relacionados.
ATE410171T1 (de) Graduierte östrogen-kontrazeptiva
PT1293210E (pt) Dispositivo e metodo anticoncepcional hormonal
BR0206367A (pt) Uso de antigestágenos para inibir o amadurecimento endométrico acelerado durante o tratamento da infertilidade
EE05344B1 (et) Ühendi (deaminohüdroksü)toremifeeni kasutamine tupekuivuse v?i seksuaaldüsfunktsiooni ravis menopausi ajal v?i järel
YU55403A (sh) Upotreba antigestagena za inhibiciju ubrzanog endometrijumskog sazrevanja tokom lečenja neplodnosti
BR0114665A (pt) Uso de antiprogestinas para a profilaxia e tratamento de doenças dependentes de hormÈnio
NZ290554A (en) Use of gonadotropin releasing hormone (GnRH) antagonist to treat the proliferation of endometrial tissue
MacGregor Female sex hormones and migraine
MEP13808A (en) Mesoprogestins for the treatment and prevention of benign hormone dependent gynecological disorders
HUP0202515A2 (hu) Mezoprogesztogének (progeszteron receptor modulátorok) alkalmazása női fogamzásgátló gyógyszer komponenseként
MY121568A (en) Use of a gnrh antagonist for the preparation of a medicament for the treatment of gonadal-steroid conditions
BR0115423A (pt) Uso de um inibidor de aromatase, uso de exemestano e triptorelina ou um sal destes farmaceuticamente aceitável, e, produto
ATE303148T1 (de) Chinolin-harnstoff-derivate zur behandlung von entzugssyndrom und durch entzugssyndrom verursachten gehirnschaden
BR0010070A (pt) Uso de org 33245, kit contraceptivo, meio combinado para a dosagem de um progestogênio e um antiprogestogênio, e, métodos de contracepção, e de tratamento de sangramento uterino irregular ou de ruptura em uma fêmea utilizando uma preparação somente de progestogênio

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A A NUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2055 DE 25/05/2010.